The detection of MNA in cfDNA of NB patients was first demonstrated by Combaret et al. in 2002 using a simple qPCR assay targeting MYCN and a reference gene (RPPH1).13 The authors reported high concordance of the MNA status between tumour and serum samples across all disease stages. This evidence concerns the gene MYCN and neuroblastoma.